Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes
Early Research in Autoimmune Disease & Fibromyalgia What It Shows and Why Its Limited Fibromyalgia: Early Signals, No Conclusions Some observational reports describe symptom improvements (pain, fatigue, opioid use) in people taking GLP-1 medications, but limitations are consistent: non-randomized design, small samples, and confounding from weight loss, sleep, and metabolic improvements
Observe how your body feels for a week before increasing
By studying the natural blood degradation products of Spadin, researchers at the University of Nice Sophia Antipolis (France) identified a 7-amino-acid fragment PE22-28 that retained and significantly improved upon Spadins TREK-1 blocking activity, while demonstrating superior in vivo stability, bioavailability, and duration of action
eating concept I teach inside The Holy Weigh
GLP AI tracks your full tirzepatide or semaglutide journeyshots or pills, estimated medication levels, meals, side effects, weight, and progress photosin one place, wherever your prescription comes from